Xencor, Inc. (XNCR) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Rhythm Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc.

Zentalis Pharmaceuticals, Inc.

Xencor, Inc.

Merus NV

AbCellera Biologics, Inc.

Vir Biotechnology, Inc.

Maravai Lifesciences Holdings, Inc.

Arcus Biosciences, Inc.

Summit Therapeutics, Inc.

Spyre Therapeutics, Inc.

Why is Xencor, Inc. ?

Poor Management Efficiency with a low ROE of 0.66%

The company has been able to generate a Return on Equity (avg) of 0.66% signifying low profitability per unit of shareholders funds

Flat results in Jun 25

DEBT-EQUITY RATIO (HY) Highest at -37.22 %

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -33.77%, its profits have fallen by -62.9%

High Institutional Holdings at 100%

These investors have better capability and resources to analyse fundamentals of companies than most retail investors.

Underperformed the market in the last 1 year

Even though the market (S&P 500) has generated returns of 12.33% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -33.77% returns

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Xencor, Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Xencor, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Xencor, Inc.

-31.8%

-0.30

69.89%

S&P 500

13.22%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

15.74%

EBIT Growth (5y)

-16.33%

EBIT to Interest (avg)

-35.77

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.49

Sales to Capital Employed (avg)

0.18

Tax Ratio

0.95%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

4.59%

ROE (avg)

0.66%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.07

EV to EBIT

-2.25

EV to EBITDA

-2.42

EV to Capital Employed

1.14

EV to Sales

2.95

PEG Ratio

Dividend Yield

ROCE (Latest)

-50.84%

ROE (Latest)

-32.74%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Bearish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company

NET SALES(Q)

At USD 43.61 MM has Grown at 37.1%

PRE-TAX PROFIT(Q)

Highest at USD -34.18 MM

NET PROFIT(Q)

Highest at USD -33.93 MM

RAW MATERIAL COST(Y)

Fallen by -7.61% (YoY

EPS(Q)

Highest at USD -0.41

-2What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at -37.22 %

Here's what is working for Xencor, Inc.

Net Sales

At USD 43.61 MM has Grown at 37.1%

over average net sales of the previous four periods of USD 31.81 MM

MOJO Watch

Near term sales trend is very positive

Net Sales (USD MM)

Pre-Tax Profit

Highest at USD -34.18 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit

Highest at USD -33.93 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (USD MM)

EPS

Highest at USD -0.41

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost

Fallen by -7.61% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Xencor, Inc.

Debt-Equity Ratio

Highest at -37.22 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio